Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Diagnostic pathology of pleuropulmonary neoplasia / / Annikka Weissferdt, Cesar A. Moran
| Diagnostic pathology of pleuropulmonary neoplasia / / Annikka Weissferdt, Cesar A. Moran |
| Autore | Weissferdt Annikka |
| Edizione | [1st ed. 2013.] |
| Pubbl/distr/stampa | New York, : Springer, 2013 |
| Descrizione fisica | 1 online resource (474 p.) |
| Disciplina |
616.99/424
616.99424 616.99424075 |
| Altri autori (Persone) | MoranCesar |
| Soggetto topico |
Tumors - Pathophysiology
Lungs - Cancer - Pathophysiology |
| ISBN | 1-4419-0787-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Diagnostic Imaging of Lung and Pleural Tumors -- 2. The Staging of Lung Cancer -- 3. Non-Small Cell Carcinomas -- 4. Neuroendocrine Carcinomas -- 5. Biphasic Tumors of the Lungs -- 6. Salivary Gland and Adnexal Type Tumors of the Lungs -- 7. Tumors Derived from Presumed Ectopic Tissues -- 8. Vascular Tumors of the Lungs -- 9. Mesenchymal Tumors of the Lungs -- 10. Lung Tumors of Uncertain Histogenesis -- 11. Malignant Lymphomas Involving Lung and Pleura -- 12. Tumors of the Pleura -- 13. Tumor-Like and Benign Tumors of the Lung -- 14. Molecular Pathology of Lung Cancer. |
| Record Nr. | UNINA-9910438001303321 |
Weissferdt Annikka
|
||
| New York, : Springer, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Lung Cancer Screening / / by: Parker, Mark S., Groves, Robert C., Kusmirek, Joanna E., Gharai, Leila Rezai, Shojaee, Samira
| Lung Cancer Screening / / by: Parker, Mark S., Groves, Robert C., Kusmirek, Joanna E., Gharai, Leila Rezai, Shojaee, Samira |
| Autore | Futrell Michelle G. |
| Pubbl/distr/stampa | New York : , : Thieme, , [2018] |
| Descrizione fisica | 1 online resource (118 pages) |
| Disciplina | 616.99424075 |
| Soggetto topico |
Lungs - Cancer - Diagnosis
Lungs - Tomography |
| ISBN |
1-63853-468-3
1-62623-514-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910795070303321 |
|
Futrell Michelle G.
|
||
| New York : , : Thieme, , [2018] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Lung Cancer Screening / / by: Parker, Mark S., Groves, Robert C., Kusmirek, Joanna E., Gharai, Leila Rezai, Shojaee, Samira
| Lung Cancer Screening / / by: Parker, Mark S., Groves, Robert C., Kusmirek, Joanna E., Gharai, Leila Rezai, Shojaee, Samira |
| Autore | Futrell Michelle G. |
| Pubbl/distr/stampa | New York : , : Thieme, , [2018] |
| Descrizione fisica | 1 online resource (118 pages) |
| Disciplina | 616.99424075 |
| Soggetto topico |
Lungs - Cancer - Diagnosis
Lungs - Tomography |
| ISBN |
1-63853-468-3
1-62623-514-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910811634603321 |
|
Futrell Michelle G.
|
||
| New York : , : Thieme, , [2018] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Lung Cancer Screening : A Population Approach / / edited by Gregory C. Kane, Julie A. Barta, Ronald E. Myers, Nathaniel R. Evans III
| Lung Cancer Screening : A Population Approach / / edited by Gregory C. Kane, Julie A. Barta, Ronald E. Myers, Nathaniel R. Evans III |
| Autore | Kane Gregory C |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (388 pages) |
| Disciplina | 616.99424075 |
| Altri autori (Persone) |
BartaJulie A
MyersRonald E Evans IIINathaniel R |
| Collana | Medicine Series |
| Soggetto topico |
Internal medicine
Oncology Internal Medicine |
| ISBN | 3-031-33596-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | SECTION 1: INTRODUCTION -- Chapter 1: The Promise of Lung Cancer Screening -- Chapter 2: A Brief History of Lung Cancer Screening -- Chapter 3: Stigma and Fatalism in Lung Cancer -- Chapter 4: Screening Eligibility, Education, and Shared Decision Making -- Chapter 5: Smoking Cessation in a Lung Cancer Screening Program - Brooke Ruane, MSN, CRNP -- Chapter 6: Why Achieving Health Equity in Lung Cancer Screening is So -- SECTION 2: APPLYING A LEARNING COMMUNITY MODEL -- Chapter 7: A Health System Learning Community -- Chapter 8: Different Approaches for Offering Lung Cancer Screening -- Chapter 9: Identifying Patients Eligible for Lung Cancer Screening -- Chapter 10: Patient Outreach and Provider Support in Lung Cancer Screening -- Chapter 11: Shared Decision Making in Lung Cancer Screening -- Chapter 12: Advances in Tobacco Treatment -- SECTION 3: ORGANIZING A QUALITY PROGRAM -- Chapter 13: Organizational Workflow for Lung Cancer -- Chapter 14: Lung-RADS and Radiology Reporting Requirements -- Chapter 15: Managing Incidental Findings -- Chapter 16: Leveraging the EMR for Continuous Quality -- Chapter 17: Minimizing Harms of Screening -- Chapter 18: A Multidisciplinary Approach -- Chapter 19: Managing Lung Cancer Screening in a Major Health Care System -- Chapter 20: Cost Considerations -- SECTION 4: TAKING CARE OF THE PATIENT -- Chapter 21: Engaging Patients from Diverse Backgrounds in Lung Cancer -- Chapter 22: Modern Management of Early-Stage Lung Cancer -- Chapter 23: The Revolution of Lung Cancer Therapeutics -- SECTION 5: ENGAGING THE COMMUNITY -- Chapter 24: Lung Cancer and Social Justice – What Do I Need to Understand? -- Chapter 25: Reaching Vulnerable Populations and Areas of Need -- Chapter 26: Lung Cancer Myths and How Do I Address Them? -- Chapter 27: How to Expand Your Program’s Reach Beyond the Healthcare System and Into the Community -- SECTION 6: DETERMINING IMPACT AT THE POPULATION LEVEL -- Chapter 28: Lung Cancer Screening–Addressing Disparities -- Chapter 29: Geocoding and Assessing a Program’s Impact -- Chapter 30: Partnering with Stakeholders for Broad Impact -- SECTION 7: ON THE HORIZON: WHAT LIES AHEAD IN LUNG CANCER SCREENING -- Chapter 31: Assessing Health Systems’ Preparedness for Addressing Lung Cancer Screening at a Population Level- Chapter 32: New Partnerships in Reaching Unique Populations -- Chapter 33: Where Do We Go From Here? -- Chapter 34: Imaging an Equitable Lung Cancer Screening. |
| Record Nr. | UNINA-9910742488903321 |
|
Kane Gregory C
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Lung Cancer Screening : Practical Aspects for Primary Care / / edited by Janelle V. Baptiste, Richard M. Schwartzstein, Carey C. Thomson
| Lung Cancer Screening : Practical Aspects for Primary Care / / edited by Janelle V. Baptiste, Richard M. Schwartzstein, Carey C. Thomson |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (131 pages) |
| Disciplina |
262
616.99424075 |
| Collana | Medicine Series |
| Soggetto topico |
Primary care (Medicine)
Respiratory organs - Diseases Primary Care Medicine Pneumology Càncer de pulmó Cribratge |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-031-10662-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Introduction -- Contents -- Chapter 1: Epidemiology of Lung Cancer and Risk Factors -- 1.1 Epidemiology of Lung Cancer -- 1.1.1 Incidence -- 1.1.2 Mortality -- 1.1.3 Stage at Presentation -- 1.1.4 Histological Subtypes -- 1.2 Lung Cancer Risk Factors -- 1.2.1 Demographic Factors -- 1.2.2 Smoking -- 1.2.3 Passive Smoking -- 1.2.4 E-Cigarettes -- 1.2.5 Air Pollution -- 1.2.6 Radon -- 1.2.7 Asbestos -- 1.2.8 Infection -- 1.2.9 Genetics and Family History -- 1.3 Conclusion -- References -- Chapter 2: Health Disparities in Lung Cancer Screening -- 2.1 Overview of Health Disparities in Lung Cancer -- 2.2 The Landscape of Health Disparities in Lung Cancer Screening -- 2.2.1 Disparities Associated with Patient Demographics Including Race and Gender -- 2.2.2 The Role of Social Determinants of Health (SDOH) -- 2.3 Barriers to Lung Cancer Screening -- 2.3.1 Barriers to Lung Cancer Screening That Act at the Health Policy Level -- 2.3.2 Barriers to Lung Cancer Screening That Act at the Health System Level -- 2.3.3 Barriers to Lung Cancer Screening That Act at the Patient Level -- 2.3.4 Barriers to Lung Cancer Screening That Act at the Health Care Provider Level -- 2.4 Overcoming Disparities in Lung Cancer Screening -- References -- Chapter 3: Best Practices in Lung Cancer Screening -- 3.1 Evidence Base for Lung Cancer Screening -- 3.1.1 Introduction -- 3.1.2 Measuring Benefits and Harms of Screening -- 3.1.3 Screening Modalities -- 3.1.3.1 Chest Radiography and Sputum Cytology -- 3.1.3.2 Low-Dose CT Scan -- Observational Studies -- 3.1.3.3 Randomized Clinical Trials -- National Lung Screening Trial -- European Randomized Lung Cancer Screening Trials -- NELSON Trial -- 3.1.4 Patient Selection -- 3.1.5 Evidence of Potential Harms -- 3.1.6 Shared Decision-Making Evidence in Lung Cancer Screening -- 3.1.7 Cost-Effectiveness of Lung Cancer Screening.
3.1.8 Smoking and Lung Cancer Screening -- 3.1.9 Non-lung nodule Findings -- 3.1.10 Evidence Needs -- 3.1.11 Conclusion -- 3.2 Quality Indicators in Lung Cancer Screening Programs -- 3.2.1 Challenges in Developing Quality Metrics in Lung Cancer Screening -- 3.2.2 Expert Consensus in Measuring Program Quality in Lung Cancer Screening -- 3.2.3 National Trends in Screening Rates, Disparities, and Targets -- 3.3 Structure and Governance -- 3.3.1 Steering Committee Governance of CT Lung Screening Programs -- 3.3.2 Program Design -- 3.3.3 Provider Continuing Education -- 3.3.4 Community Outreach -- 3.3.5 Measuring Outcomes -- 3.3.6 Research Oversight -- 3.4 Navigation -- 3.4.1 Introduction -- 3.4.2 Office/Department-Based Navigation -- 3.4.3 Lung Cancer Screening Program Navigation -- 3.4.4 The Benefit of Nursing Navigation in Cancer Screening -- 3.4.5 Navigating Lung Cancer Screening in the Electronic Medical Record -- 3.4.6 Navigation Summary -- References -- Chapter 4: Implementing Lung Cancer Screening in Clinical Practice -- 4.1 Lung Cancer Screening Eligibility Criteria and Confirmation of Eligibility -- 4.1.1 Current Eligibility Criteria for Lung Cancer Screening -- 4.1.2 Determining and Ensuring Eligibility for Lung Cancer Screening (LCS) -- 4.1.3 Suggested Areas of Research -- 4.2 Barriers to Implementing Lung Cancer Screening (LCS) in Clinical Practice -- 4.2.1 Discussing Barriers to Implementation of LCS in Primary Care -- 4.2.2 Lung Cancer Screening Is Complex and Costly -- 4.2.3 External Influences Is a Barrier to Lung Cancer Screening Implementation -- 4.2.4 Future Direction -- 4.3 Integration of Lung Cancer Screening into the Electronic Health Record -- 4.3.1 Areas of Focus for Leveraging the EHR -- 4.3.1.1 Documentation of Lung Cancer Risk Factors -- 4.3.2 EHR Support for Identifying LCS-Eligible Individuals. 4.3.3 Tracking LDCT Findings for Follow-Up -- 4.3.4 Research Gaps -- 4.3.5 Future Directions -- 4.4 Insurance Coverage and Prior Authorization of Lung Cancer Screening -- 4.4.1 Private Insurance Coverage -- 4.4.2 Medicare Coverage -- 4.4.3 Medicaid Coverage -- 4.4.4 Prior Authorization -- References -- Chapter 5: Innovations in Integrating Smoking Cessation and the Shared Decision-Making Discussion into Lung Cancer Screening -- 5.1 Components of a Shared Decision-Making Discussion -- 5.2 Challenges in Shared Decision-Making Decisions: Embracing Uncertainty -- 5.2.1 Biology of the Tumor -- 5.2.2 Concept of False Positives -- 5.2.3 Relative Versus Absolute Risk Reduction -- 5.2.4 Addressing Uncertainty in Lung Cancer Screening -- 5.3 Smoking Cessation -- 5.3.1 Evidence-Based Tobacco Treatment -- 5.3.2 Tobacco Therapy and the Shared Decision -- 5.3.3 Personalized Risk Assessment to Support Quitting -- 5.3.4 Barriers to Quitting -- 5.4 Innovation in Lung Screening and Decision Support Tools -- 5.4.1 What Is Innovation? -- 5.4.2 Current Educational Tools Are Lacking -- 5.4.3 Experiential Learning and Understanding Pulmonary Nodules -- 5.4.4 Measuring the Effectiveness of a Tactile Lung Nodule Tool -- 5.4.5 Innovations for Rural Engagement and Supporting Quitting -- 5.4.6 Virtual Reality: Next Generational Teaching Tool -- References -- Chapter 6: Lung Cancer Screening Results and Tracking -- 6.1 Ordering a LCS CT -- 6.2 Standardized Reporting Protocols and National Registry Requirements -- 6.3 Managing Screening Findings on Lung Cancer Screening CTs -- 6.4 Managing Incidental Findings on Lung Cancer Screening CT -- 6.5 Updates in Lung Cancer Screening Technology -- 6.6 Women and Lung Cancer Screening -- References -- Index. |
| Record Nr. | UNINA-9910616209103321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Lung cancer screening / / Mark S. Parker [and four others]
| Lung cancer screening / / Mark S. Parker [and four others] |
| Pubbl/distr/stampa | New York : , : Thieme, , [2018] |
| Descrizione fisica | 1 online resource (118 pages) |
| Disciplina | 616.99424075 |
| Soggetto topico |
Lungs - Cancer - Diagnosis
Lungs - Tomography |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-62623-514-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910467664803321 |
| New York : , : Thieme, , [2018] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||